menu
    • menu

    Company profile for Immunovia

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immunovia AB was founded in 2007 by researchers from the Department of Immunotechnology at Lund University and CREATE Health (the Center for Translational Cancer Research) in Lund, Sweden. Our strategy is to decipher the wealth of information available in blood – and translate it into clinically useful tools to diagnose complex diseases such as cancer and autoimmune disorders, earlier and more accurately than previously p...
    Immunovia AB was founded in 2007 by researchers from the Department of Immunotechnology at Lund University and CREATE Health (the Center for Translational Cancer Research) in Lund, Sweden. Our strategy is to decipher the wealth of information available in blood – and translate it into clinically useful tools to diagnose complex diseases such as cancer and autoimmune disorders, earlier and more accurately than previously possible. Immunovia’s unique technology platform – IMMrayTM – is an antibody-based multiplex test that is designed to provide a snapshot of the immune system response – based on the information available

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmunoviaSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Medicon Village Scheelevägen 2, Lund
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://immunovia.com/
    Linkedin
    Linkedin
    https://se.linkedin.com/company/immunovia-ab
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/immunovia?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Onconetix's Proteomedix Licenses Ip To Immunovia
    Onconetix's Proteomedix Licenses Ip To Immunovia

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153852/0/en/Onconetix-announces-its-subsidiary-Proteomedix-licenses-manufacturing-IP-to-Immunovia-enabling-them-to-independently-produce-key-reagents-for-their-pancreatic-cancer-test-PancreaSu.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    Immunovia's Clariti Study Selected For Leading GI Conference
    Immunovia's Clariti Study Selected For Leading GI Conference

    03 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunovias-clariti-study-results-selected-for-prestigious-presentation-at-the-worlds-largest-gastroenterology-conference-302389808.html

    PR NEWSWIRE
    03 Mar 2025
    Share Share
    Immunovia Study Published in Leading Protein Research Journal
    Immunovia Study Published in Leading Protein Research Journal

    20 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunovia-discovery-study-published-in-top-protein-research-journal-302337208.html

    PR NEWSWIRE
    20 Dec 2024
    Share Share
    End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding
    End of the Year 2024 Letter from Immunovia CEO Jeff Borcherding

    19 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/end-of-the-year-2024-letter-from-immunovia-ceo-jeff-borcherding-302336286.html

    PR NEWSWIRE
    19 Dec 2024
    Share Share
    Immunovia CEO and Board to Fully Exercise TO2 Warrants
    Immunovia CEO and Board to Fully Exercise TO2 Warrants

    18 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunovia-ceo-and-board-members-announce-intention-to-fully-exercise-their-to2-warrants-302334989.html

    PR NEWSWIRE
    18 Dec 2024
    Share Share
    Immunovia to Host Webcast on Pancreatic Cancer Test Validation
    Immunovia to Host Webcast on Pancreatic Cancer Test Validation

    16 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/immunovia-to-host-a-webcast-with-the-opportunity-to-learn-more-about-the-positive-clinical-validation-of-its-next-generation-pancreatic-cancer-test-302332369.html

    PR NEWSWIRE
    16 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search